GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exicure Inc (STU:2H0A) » Definitions » Additional Paid-In Capital

Exicure (STU:2H0A) Additional Paid-In Capital : €176.61 Mil(As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Exicure Additional Paid-In Capital?


Exicure's quarterly additional paid-in capital increased from Jun. 2023 (€177.70 Mil) to Sep. 2023 (€180.44 Mil) but then stayed the same from Sep. 2023 (€180.44 Mil) to Dec. 2023 (€176.61 Mil).

Exicure's annual additional paid-in capital increased from Dec. 2021 (€160.45 Mil) to Dec. 2022 (€177.07 Mil) but then declined from Dec. 2022 (€177.07 Mil) to Dec. 2023 (€176.61 Mil).


Exicure Additional Paid-In Capital Historical Data

The historical data trend for Exicure's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exicure Additional Paid-In Capital Chart

Exicure Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 145.86 137.59 160.45 177.07 176.61

Exicure Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 177.07 179.02 177.70 180.44 176.61

Exicure Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Exicure Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Exicure's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Exicure (STU:2H0A) Business Description

Industry
Traded in Other Exchanges
Address
2430 N. Halsted Street, Suite 410, Chicago, IL, USA, 60614
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.

Exicure (STU:2H0A) Headlines

No Headlines